Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 154Neoplasms 128Prostatic Neoplasms 69Lung Neoplasms 65Colorectal Neoplasms 64Motor Activity 36Uterine Cervical Neoplasms 35Pancreatic Neoplasms 25Ovarian Neoplasms 23Head and Neck Neoplasms 23Brain Neoplasms 22Rectal Neoplasms 21Carcinoma, Hepatocellular 21Carcinoma, Non-Small-Cell Lung 19Glioblastoma 18Colonic Neoplasms 18Stomach Neoplasms 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Hematologic Neoplasms 16Anxiety Disorders 16Disease 15Depression 15Papillomavirus Infections 14Leukemia 14Multiple Myeloma 13Melanoma 12Glioma 12Squamous Cell Carcinoma of Head and Neck 11Urinary Bladder Neoplasms 10Thyroid Neoplasms 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Dihydropyrimidine Dehydrogenase Deficiency × 30 days × Clear all
NCT04541381 2026-05-07

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

University of Chicago

Phase NA Suspended
860 enrolled
BreastGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Dihydropyrimidine Dehydrogenase Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡